Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group

Recent studies have shown that microtransplant (MST) could improve outcome of patients with elderly acute myeloid leukemia (EAML). To further standardize the MST therapy and improve outcomes in EAML patients, based on analysis of the literature on MST, especially MST with EAML from January 1st, 2011...

Full description

Bibliographic Details
Main Authors: Huisheng Ai, Nelson J. Chao, David A. Rizzieri, Xiaojun Huang, Thomas R. Spitzer, Jianxiang Wang, Mei Guo, Armand Keating, Elizabeth F. Krakow, Didier Blaise, Jun Ma, Depei Wu, John Reagan, Usama Gergis, Rafael F. Duarte, Preet M. Chaudhary, Kaixun Hu, Changlin Yu, Qiyun Sun, Ephraim Fuchs, Bo Cai, Yajing Huang, Jianhui Qiao, David Gottlieb, Kirk R. Schultz, Mingyao Liu, Xiequn Chen, Wenming Chen, Jianmin Wang, Xiaohui Zhang, Jianyong Li, He Huang, Zimin Sun, Fei Li, Linhua Yang, Liansheng Zhang, Lijuan Li, Kaiyan Liu, Jie Jin, Qifa Liu, Daihong Liu, Chunji Gao, Chuanbo Fan, Li Wei, Xi Zhang, Liangding Hu, Weijing Zhang, Yuyang Tian, Weidong Han, Jun Zhu, Zhijian Xiao, Daobin Zhou, Bolong Zhang, Yongqian Jia, Yongqing Zhang, Xiaoxiong Wu, Xuliang Shen, Xuzhang Lu, Xinrong Zhan, Xiuli Sun, Yi Xiao, Jingbo Wang, Xiaodong Shi, Bo Zheng, Jieping Chen, Banghe Ding, Zhao Wang, Fan Zhou, Mei Zhang, Yizhuo Zhang, Jie Sun, Bing Xia, Baoan Chen, Liangming Ma
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402302131X
_version_ 1797837035707301888
author Huisheng Ai
Nelson J. Chao
David A. Rizzieri
Xiaojun Huang
Thomas R. Spitzer
Jianxiang Wang
Mei Guo
Armand Keating
Elizabeth F. Krakow
Didier Blaise
Jun Ma
Depei Wu
John Reagan
Usama Gergis
Rafael F. Duarte
Preet M. Chaudhary
Kaixun Hu
Changlin Yu
Qiyun Sun
Ephraim Fuchs
Bo Cai
Yajing Huang
Jianhui Qiao
David Gottlieb
Kirk R. Schultz
Mingyao Liu
Xiequn Chen
Wenming Chen
Jianmin Wang
Xiaohui Zhang
Jianyong Li
He Huang
Zimin Sun
Fei Li
Linhua Yang
Liansheng Zhang
Lijuan Li
Kaiyan Liu
Jie Jin
Qifa Liu
Daihong Liu
Chunji Gao
Chuanbo Fan
Li Wei
Xi Zhang
Liangding Hu
Weijing Zhang
Yuyang Tian
Weidong Han
Jun Zhu
Zhijian Xiao
Daobin Zhou
Bolong Zhang
Yongqian Jia
Yongqing Zhang
Xiaoxiong Wu
Xuliang Shen
Xuzhang Lu
Xinrong Zhan
Xiuli Sun
Yi Xiao
Jingbo Wang
Xiaodong Shi
Bo Zheng
Jieping Chen
Banghe Ding
Zhao Wang
Fan Zhou
Mei Zhang
Yizhuo Zhang
Jie Sun
Bing Xia
Baoan Chen
Liangming Ma
author_facet Huisheng Ai
Nelson J. Chao
David A. Rizzieri
Xiaojun Huang
Thomas R. Spitzer
Jianxiang Wang
Mei Guo
Armand Keating
Elizabeth F. Krakow
Didier Blaise
Jun Ma
Depei Wu
John Reagan
Usama Gergis
Rafael F. Duarte
Preet M. Chaudhary
Kaixun Hu
Changlin Yu
Qiyun Sun
Ephraim Fuchs
Bo Cai
Yajing Huang
Jianhui Qiao
David Gottlieb
Kirk R. Schultz
Mingyao Liu
Xiequn Chen
Wenming Chen
Jianmin Wang
Xiaohui Zhang
Jianyong Li
He Huang
Zimin Sun
Fei Li
Linhua Yang
Liansheng Zhang
Lijuan Li
Kaiyan Liu
Jie Jin
Qifa Liu
Daihong Liu
Chunji Gao
Chuanbo Fan
Li Wei
Xi Zhang
Liangding Hu
Weijing Zhang
Yuyang Tian
Weidong Han
Jun Zhu
Zhijian Xiao
Daobin Zhou
Bolong Zhang
Yongqian Jia
Yongqing Zhang
Xiaoxiong Wu
Xuliang Shen
Xuzhang Lu
Xinrong Zhan
Xiuli Sun
Yi Xiao
Jingbo Wang
Xiaodong Shi
Bo Zheng
Jieping Chen
Banghe Ding
Zhao Wang
Fan Zhou
Mei Zhang
Yizhuo Zhang
Jie Sun
Bing Xia
Baoan Chen
Liangming Ma
author_sort Huisheng Ai
collection DOAJ
description Recent studies have shown that microtransplant (MST) could improve outcome of patients with elderly acute myeloid leukemia (EAML). To further standardize the MST therapy and improve outcomes in EAML patients, based on analysis of the literature on MST, especially MST with EAML from January 1st, 2011 to November 30th, 2022, the International Microtransplant Interest Group provides recommendations and considerations for MST in the treatment of EAML. Four major issues related to MST for treating EAML were addressed: therapeutic principle of MST (1), candidates for MST (2), induction chemotherapy regimens (3), and post-remission therapy based on MST (4). Others included donor screening, infusion of donor cells, laboratory examinations, and complications of treatment.
first_indexed 2024-04-09T15:19:25Z
format Article
id doaj.art-856fec91f1344a8b9074383ae4ab2604
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-09T15:19:25Z
publishDate 2023-04-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-856fec91f1344a8b9074383ae4ab26042023-04-29T14:51:39ZengElsevierHeliyon2405-84402023-04-0194e14924Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest groupHuisheng Ai0Nelson J. Chao1David A. Rizzieri2Xiaojun Huang3Thomas R. Spitzer4Jianxiang Wang5Mei Guo6Armand Keating7Elizabeth F. Krakow8Didier Blaise9Jun Ma10Depei Wu11John Reagan12Usama Gergis13Rafael F. Duarte14Preet M. Chaudhary15Kaixun Hu16Changlin Yu17Qiyun Sun18Ephraim Fuchs19Bo Cai20Yajing Huang21Jianhui Qiao22David Gottlieb23Kirk R. Schultz24Mingyao Liu25Xiequn Chen26Wenming Chen27Jianmin Wang28Xiaohui Zhang29Jianyong Li30He Huang31Zimin Sun32Fei Li33Linhua Yang34Liansheng Zhang35Lijuan Li36Kaiyan Liu37Jie Jin38Qifa Liu39Daihong Liu40Chunji Gao41Chuanbo Fan42Li Wei43Xi Zhang44Liangding Hu45Weijing Zhang46Yuyang Tian47Weidong Han48Jun Zhu49Zhijian Xiao50Daobin Zhou51Bolong Zhang52Yongqian Jia53Yongqing Zhang54Xiaoxiong Wu55Xuliang Shen56Xuzhang Lu57Xinrong Zhan58Xiuli Sun59Yi Xiao60Jingbo Wang61Xiaodong Shi62Bo Zheng63Jieping Chen64Banghe Ding65Zhao Wang66Fan Zhou67Mei Zhang68Yizhuo Zhang69Jie Sun70Bing Xia71Baoan Chen72Liangming Ma73Chinese PLA General Hospital, China; Corresponding author. Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, 8 Dongdajie Street, Beijing 100071, China.Duke University, USA; Corresponding author. Division of Hematologic Malignancies and Cellular Therapy/BMT, Global Cancer/Duke Cancer Institute/Duke Global Health Institute, 2400 Pratt St, Suite 5029, Box 3961, Durham, NC 27710, USA.Novant Health, USAPeople's Hospital of Peking University, ChinaMassachusetts General Hospital, USAChinese Academy of Medical Sciences Hematology Hospital, ChinaChinese PLA General Hospital, ChinaUniversity of Toronto, CanadaFred Hutchinson Cancer Research Center, USAMarseille Cancer Research Center, FranceHarbin Institute of Hematology and Oncology, ChinaThe First Affiliated Hospital of Soochow University, ChinaThe Warren Alpert Medical School of Brown University, USASidney Kimmel Cancer Center, USAHospital Universitario Puerta de Hierro, SpainKeck School of Medicine of University of Southern California, USAChinese PLA General Hospital, ChinaChinese PLA General Hospital, ChinaChinese PLA General Hospital, ChinaJohns Hopkins University, USAChinese PLA General Hospital, ChinaChinese PLA General Hospital, China; Innovvy (Beijing) Biomedical Technology Co.Ltd, ChinaChinese PLA General Hospital, ChinaWestmead Hospital, AustraliaBC Children's Hospital and Research Institute, CanadaUniversity of Toronto, CanadaAffiliated Hospital of Northwest University, ChinaBeijing Chao-yang Hospital, Capital Medical University, ChinaChanghai Hospital of Naval Medical University, ChinaPeople's Hospital of Peking University, ChinaJiangsu Province Hospital, ChinaThe First Affiliated Hospital, Zhejiang University School of Medicine, ChinaThe First Affiliated Hospital of University of Science and Technology of China, ChinaThe First Affiliated Hospital of Nanchang University, ChinaThe Second Hospital of Shanxi Medical University, ChinaLanzhou University Second Hospital, ChinaLanzhou University Second Hospital, ChinaPeople's Hospital of Peking University, ChinaThe First Affiliated Hospital, Zhejiang University School of Medicine, ChinaNanfang Hospital of Southern Medical University, ChinaChinese PLA General Hospital, ChinaChinese PLA General Hospital, ChinaQingdao Hiser Hospital, ChinaChengdu Fifth People's Hospital, ChinaMedical Center of Hematology, Xinqiao Hospital, Army Medical University, Jinfeng Laboratory, ChinaChinese PLA General Hospital, ChinaBeijing Shijitan Hospital, ChinaHainan Cancer Hospital, ChinaChinese PLA General Hospital, ChinaBeijing Cancer Hospital, ChinaChinese Academy of Medical Sciences Hematology Hospital, ChinaPeking Union Medical College Hospital, ChinaHarbin Institute of Hematology and Oncology, ChinaWest China Hospital of Sichuan University, ChinaChinese PLA General Hospital, ChinaChinese PLA General Hospital, ChinaHeping Hospital Affiliated to Changzhi Medical College, ChinaChangzhou Second People's Hospital, ChinaXinxiang Center Hospital, ChinaThe First Affiliated Hospital of Dalian Medical University, ChinaTongji Hospital, Tongji Medical College of HUST, ChinaAerospace Center Hospital, ChinaCapital Institute of Pediatrics, ChinaGeneral Hospital of Ningxia Medical University, ChinaSouthwest Hospital of Army Medical University, ChinaHuai'an First People's Hospital, ChinaBeijing Friendship Hospital, Capital Medical University, ChinaGeneral Hospital of Northern Theater Command, ChinaThe First Affiliated Hospital of Xi'an Jiaotong University, ChinaSun Yat-sen University Cancer Center, ChinaThe First Affiliated Hospital, Zhejiang University School of Medicine, ChinaTianjin Medical University Cancer Institute and Hospital, ChinaZhongda Hospital, Southeast University, ChinaShanxi Bethune Hospital, ChinaRecent studies have shown that microtransplant (MST) could improve outcome of patients with elderly acute myeloid leukemia (EAML). To further standardize the MST therapy and improve outcomes in EAML patients, based on analysis of the literature on MST, especially MST with EAML from January 1st, 2011 to November 30th, 2022, the International Microtransplant Interest Group provides recommendations and considerations for MST in the treatment of EAML. Four major issues related to MST for treating EAML were addressed: therapeutic principle of MST (1), candidates for MST (2), induction chemotherapy regimens (3), and post-remission therapy based on MST (4). Others included donor screening, infusion of donor cells, laboratory examinations, and complications of treatment.http://www.sciencedirect.com/science/article/pii/S240584402302131XMicrotransplantAcute myeloid leukemiaElderlyRecommendations and considerations
spellingShingle Huisheng Ai
Nelson J. Chao
David A. Rizzieri
Xiaojun Huang
Thomas R. Spitzer
Jianxiang Wang
Mei Guo
Armand Keating
Elizabeth F. Krakow
Didier Blaise
Jun Ma
Depei Wu
John Reagan
Usama Gergis
Rafael F. Duarte
Preet M. Chaudhary
Kaixun Hu
Changlin Yu
Qiyun Sun
Ephraim Fuchs
Bo Cai
Yajing Huang
Jianhui Qiao
David Gottlieb
Kirk R. Schultz
Mingyao Liu
Xiequn Chen
Wenming Chen
Jianmin Wang
Xiaohui Zhang
Jianyong Li
He Huang
Zimin Sun
Fei Li
Linhua Yang
Liansheng Zhang
Lijuan Li
Kaiyan Liu
Jie Jin
Qifa Liu
Daihong Liu
Chunji Gao
Chuanbo Fan
Li Wei
Xi Zhang
Liangding Hu
Weijing Zhang
Yuyang Tian
Weidong Han
Jun Zhu
Zhijian Xiao
Daobin Zhou
Bolong Zhang
Yongqian Jia
Yongqing Zhang
Xiaoxiong Wu
Xuliang Shen
Xuzhang Lu
Xinrong Zhan
Xiuli Sun
Yi Xiao
Jingbo Wang
Xiaodong Shi
Bo Zheng
Jieping Chen
Banghe Ding
Zhao Wang
Fan Zhou
Mei Zhang
Yizhuo Zhang
Jie Sun
Bing Xia
Baoan Chen
Liangming Ma
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group
Heliyon
Microtransplant
Acute myeloid leukemia
Elderly
Recommendations and considerations
title Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group
title_full Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group
title_fullStr Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group
title_full_unstemmed Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group
title_short Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group
title_sort expert consensus on microtransplant for acute myeloid leukemia in elderly patients report from the international microtransplant interest group
topic Microtransplant
Acute myeloid leukemia
Elderly
Recommendations and considerations
url http://www.sciencedirect.com/science/article/pii/S240584402302131X
work_keys_str_mv AT huishengai expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT nelsonjchao expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT davidarizzieri expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT xiaojunhuang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT thomasrspitzer expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT jianxiangwang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT meiguo expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT armandkeating expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT elizabethfkrakow expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT didierblaise expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT junma expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT depeiwu expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT johnreagan expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT usamagergis expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT rafaelfduarte expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT preetmchaudhary expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT kaixunhu expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT changlinyu expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT qiyunsun expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT ephraimfuchs expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT bocai expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT yajinghuang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT jianhuiqiao expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT davidgottlieb expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT kirkrschultz expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT mingyaoliu expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT xiequnchen expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT wenmingchen expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT jianminwang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT xiaohuizhang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT jianyongli expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT hehuang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT ziminsun expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT feili expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT linhuayang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT lianshengzhang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT lijuanli expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT kaiyanliu expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT jiejin expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT qifaliu expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT daihongliu expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT chunjigao expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT chuanbofan expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT liwei expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT xizhang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT liangdinghu expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT weijingzhang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT yuyangtian expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT weidonghan expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT junzhu expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT zhijianxiao expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT daobinzhou expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT bolongzhang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT yongqianjia expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT yongqingzhang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT xiaoxiongwu expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT xuliangshen expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT xuzhanglu expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT xinrongzhan expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT xiulisun expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT yixiao expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT jingbowang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT xiaodongshi expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT bozheng expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT jiepingchen expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT bangheding expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT zhaowang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT fanzhou expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT meizhang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT yizhuozhang expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT jiesun expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT bingxia expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT baoanchen expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup
AT liangmingma expertconsensusonmicrotransplantforacutemyeloidleukemiainelderlypatientsreportfromtheinternationalmicrotransplantinterestgroup